ENTPD1 p.Thr451Pro
c.1351A>C · rs2494721086 · VCV1714543
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5957 | likely pathogenic |
|---|---|---|
| REVEL | 0.6 | indeterminate |
| SaProt | LLR -8.68 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 9.3 | GERP 2.7, phastCons 1 |
| Regional constraint | o/e 0.83 | unconstrained · MANE · 110 kb · p 3.1e-05 · regional, not allelic |
| Overall | ||
| CADD | 27.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ENTPD1
- Protein
- p.Thr451Pro
- Coding
- c.1351A>C
- dbSNP
- rs2494721086
- Type
- single nucleotide variant
- Location
- chr10:95866201 (GRCh38)
Disease context
hereditary spastic paraplegia 64 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal recessive spastic paraplegia type 64 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/entpd1-p-thr451pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown